Stock Market News 2024-05-31
401 news published.
Today’s stock market highlights underscore significant developments across various sectors, particularly in pharmaceuticals, technology, and consumer goods. Here are the key events shaping the market:
- Regeneron Pharmaceuticals and Sanofi received a three-month extension from the U.S. FDA for their priority review of Dupixent for treating COPD patients, now due by September 27, 2024. This follows additional efficacy analyses requested by the FDA. Read More
- STMicroelectronics is set to establish the world’s first fully integrated silicon carbide facility in Italy with a €5 billion investment aimed at supporting automotive electrification. Production is expected to start in 2026. Read More
- Gilead Sciences presented results from its Phase 3 EVOKE-01 study at the ASCO 2024 meeting. Although the study did not meet its primary endpoint, it showed a 16% reduction in mortality risk with Trodelvy compared to docetaxel. Read More
- Moderna received FDA approval for its mRNA RSV vaccine, mRESVIA, targeting adults aged 60 and older. The vaccine showed an efficacy of 83.7% in trials. Plans for rollout in the U.S. are set for the 2024/2025 respiratory season. Read More
- UBS finalized its merger with Credit Suisse, creating a single entity as Credit Suisse is deregistered. This completion is expected to unlock cost and capital benefits moving forward. Read More
- Ionis Pharmaceuticals released positive Phase 3 results for its investigational drug donidalorsen, which showed >90% reduction in hereditary angioedema attacks, enhancing its potential for regulatory approval. Read More
- Walmart is expanding its InHome delivery service to an additional 10 million U.S. households, now reaching over 45 million homes. The service delivers groceries directly into customer kitchens, enhancing convenience. Read More
- Flutter Entertainment has completed its transition to a primary listing on the NYSE, reflecting its strategic focus on the U.S. sports betting market. Read More
These pivotal updates reflect ongoing market dynamics and investor sentiments as companies push for growth, innovation, and compliance with regulatory standards.
Don't miss out on market-moving news. Bookmark this page and check back regularly for the most recent updates on stocks, sectors, and the overall market landscape. Stay informed, stay ahead, and make smarter investment choices with our comprehensive stock news coverage.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement